Next Article in Journal
Fabrication, Evaluation, and Antioxidant Properties of Carrier-Free Curcumin Nanoparticles
Next Article in Special Issue
Prediction of ADMET Properties of Anti-Breast Cancer Compounds Using Three Machine Learning Algorithms
Previous Article in Journal
Photoinitiated Cationic Ring-Opening Polymerization of Octamethylcyclotetrasiloxane
Previous Article in Special Issue
Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors
 
 
Article
Peer-Review Record

A Novel Approach to Develop New and Potent Inhibitors for the Simultaneous Inhibition of Protease and Helicase Activities of HCV NS3/4A Protease: A Computational Approach

Molecules 2023, 28(3), 1300; https://doi.org/10.3390/molecules28031300
by Muhammad Riaz 1, Ashfaq Ur Rehman 2, Muhammad Waqas 3, Asaad Khalid 4,5, Ashraf N. Abdalla 6, Arif Mahmood 7, Junjian Hu 8,* and Abdul Wadood 1,*
Reviewer 2:
Molecules 2023, 28(3), 1300; https://doi.org/10.3390/molecules28031300
Submission received: 19 December 2022 / Revised: 18 January 2023 / Accepted: 19 January 2023 / Published: 29 January 2023
(This article belongs to the Special Issue Computational Strategy for Drug Design)

Round 1

Reviewer 1 Report

 

the article with title " A Novel Approach to Develop New and Potent Inhibitors for 2 the Simultaneous Inhibition of Protease and Helicase Activities 3 of HCV NS3/4A Protease: A computational Approach" show a good results as dry lab applications and Computational and Theoretical Chemistry, the quality of the figures are good but

1-the author didn’t mention the origin of the tested compound or at least reference for them.

2- the reference should be renewed as I found a reference from 1989 , 2001, 2004   

 

Author Response

Please see the attached file for comments.

Author Response File: Author Response.pdf

Reviewer 2 Report

Dear Editor,

The study, entitled ‘A Novel Approach to Develop New and Potent Inhibitors for 2 the Simultaneous Inhibition of Protease and Helicase Activities 3 of HCV NS3/4A Protease: A computational Approach’ with manuscript number molecules-2139525, discusses the design of 12 new NS3/4A protease inhibitors via the employment of computer-aided techniques. The study is interesting for researchers in the relevant field. Some minor suggestions are provided below:

- Hep C is a worldwide threatening disease; therefore more statistics should be given in the abstract part regarding the cases in Europe, USA, for instance.

- It is not clear in the abstract part which side of the protein is targeted and how this is rationalized.

- Scheme 2 misses two describe the precursor molecules. Caption should be revised.

- RECAP Analysis is used to fragment a molecule by breaking some bonds which are 169 likely to be those that can be reformed by common reliable chemistry. The methodology 170 is similar to that of [34] and [35]. This sentence does not make sense. 34 and 35 should be clarified in the text.

- Line 177 Thirty one different fragments 177 were generated from the above mentioned seven inhibitors according to simple retrosynthetic analysis rules. Citation is missing.

-   Figure 4 also misses sufficient caption to introduce the compounds.

- What is the importance of selected drug-likely properties?

- I don’t think there is need for the nomenclature of the 12 title compounds.

- Although it is a computational study, one wonders at least one of those compounds exact activity measured.

Author Response

Please find the attachment.

Author Response File: Author Response.pdf

Back to TopTop